Drug recall · March 30, 2022
Lidocaine Ointment USP recall
Why: cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lidocaine Ointment USP, 5%, Net Wt 35.44 g (1 1/4 oz) tube, Rx Only, Teligent Pharma, Inc., Buena, New Jersey 08310, NDC 52565-008-14.
- Lots / codes
Batch: 16389, Exp. 2/29/2024; 16452, Exp. 2/29/2024
- Quantity
- 100,256 tubes
- Company
- Teligent Pharma, Inc., Buena, NJ
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- March 15, 2022 · Voluntary: Firm initiated
- Classified
- March 21, 2022
- Reported
- March 30, 2022
- Ended
- June 17, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.